Virax Biolabs Group annual gross margin
2021
2023
2024
2025
Virax Biolabs Group Gross Margin Growth & History (VRAX)
Virax Biolabs Group's gross margin was −838.21% for fiscal 2025.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | −838.21% | −870.55 pp |
| 2024 | 2024-03-31 | 32.34% | +48.29 pp |
| 2023 | 2023-03-31 | −15.94% | −8.33 pp |
| 2021 | 2021-04-01 | −7.62% | — |
Virax Biolabs Group quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Virax Biolabs Group gross margin trends
Across the available reported history, Virax Biolabs Group's gross margin decreased from 32.34% to −838.21%, a change of −870.55 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group filings at SEC.gov ↗